Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2019-03-21 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the full exercise of the over-allotment option, stabilizing actions, and the end of the stabilization period related to a global offering of shares by CStone Pharmaceuticals. It includes details about share allotment, shareholding structure changes, use of proceeds, and compliance with public float requirements. The document is regulatory in nature, related to capital market activities, specifically about share issuance and stabilization after an IPO. It is not a full financial report, earnings release, or management discussion. It is not a proxy, AGM material, or legal proceeding. The key focus is on capital issuance and share structure changes following the exercise of an over-allotment option. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about financing activities, not just a brief announcement or a certification, so it is not RPA or RNS.
2019-03-21 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notification of a board meeting scheduled to consider the publication of the audited annual results and proposed final dividend. It is an announcement about an upcoming board meeting rather than the actual annual report or financial results. The document length is short (1581 characters), and it does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a board meeting and not the report itself.
2019-03-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-03-15 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from CStone Pharmaceuticals regarding the date of a board meeting to consider and approve the annual results for the year ended 31 December 2018 and the recommendation on the payment of a final dividend. It does not contain any actual financial data or detailed report content. The length is only 1529 characters, which is quite short and typical for an announcement rather than a full report. The document explicitly states the meeting will consider the annual results and dividend, indicating the report itself is not included here. According to the 'MENU VS MEAL' rule, this is an announcement about the timing of a report or decision, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2019-03-12 English
RULES OF PROCEDURE FOR SUPERVISORY COMMITTEE OF YANZHOU COAL MINING COMPANY LIMITED
Governance Information Classification · 95% confidence The document is titled 'Rules of Procedure for Supervisory Committee' of Yanzhou Coal Mining Company Limited and contains detailed provisions about the constitution, functions, powers, meetings, and operational procedures of the Supervisory Committee. It is a governance document outlining internal rules and supervisory mechanisms rather than a financial report, announcement, or regulatory filing. There is no indication of financial data, audit results, voting results, or other report types. The content aligns with governance practices and internal company rules. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed procedural content support this classification with high confidence.
2019-03-07 English
RULES OF PROCEDURES FOR THE BOARD OF DIRECTORS OF YANZHOU COAL MINING COMPANY LIMITED
Governance Information Classification · 100% confidence The document is titled 'Rules of Procedures for the Board of Directors of Yanzhou Coal Mining Company Limited' and contains detailed provisions about the duties, powers, and operational procedures of the company's board of directors. It includes chapters on general provisions, duties and powers of the board, chairman, independent directors, and other governance-related topics. There is no indication that this is a financial report, earnings release, or announcement of voting results. Instead, it is a governance document outlining internal rules and structure of the board. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is a full governance report, not a brief announcement or regulatory filing.
2019-03-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.